Author

Ali R. Saadatmand

Heidelberg University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Adel ElsherbinyiD· 1 shared Almut SchulzeiD· 1 shared Christian U. OeingiD· 1 shared Coenraad WithaariD· 1 shared Eric SchogeriD· 1 shared Friederike C. SchreiteriD· 1 shared Harikrishnareddy Paluvai· 1 shared Inês Falcão‐PiresiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Adel ElsherbinyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Selective class IIa HDAC inhibition reverses diastolic dysfunction in cardiometabolic HFpEF

Jiale Huang, Friederike C. Schreiter, Junyu Fan, Zihao Chen, Harikrishnareddy Paluvai, Coenraad Withaar, Christian U. Oeing, Ali R. Saadatmand, Eric Schoger, Shaza Haydar, Adel Elsherbiny, Marco Hagenmueller, Karine Lapouge, Nuno Guimarães‐Camboa, Inês Falcão‐Pires, , Johannes Backs

This study shows that selective class IIa HDAC inhibition improves diastolic dysfunction in HFpEF without adverse effects.

bioRxiv · Jan 14, 2026 · PreprintMolecular Biology